2018

  • New Dedicated Research Centre opens in Czech Republic.

2017

  • Integration with Radiant Sites in US, forming biggest Site Network.
  • Optimal Sites join Synexus in US.

Capacity expansion:

  • Berlin DRS relocation (Germany).
  • Budapest DRS additional space (Hungary).
  • Wroclaw DRS relocation (Poland).
  • Gdynia DRS relocation (Poland).
  • Stara Zagora DRS (Bulgaria).
  • Teeside Hospital DRS (UK).

2016

  • Synexus enters US market with Acquisition of Research Across America.

2015

  • Synexus Management buyout with the backing of LDC.
  • Bulgaria: Opening of first Synexus Dedicated Research Site in Sofia.
  • Poland: Fifth Synexus Dedicated Research Site opened in Gdansk.
  • Romania: Opening of first Synexus Dedicated Research Site in Bucharest.

2014

  • Synexus Romania established.
  • UK: Pioneering Synexus Dedicated Research Site opened at Hexham Hospital in partnership with the National Health Service.
  • Poland: Opening of new Synexus Dedicated Research Site in Poznan.
  • South Africa: Acquisition of Helderberg Clinical Trials Centre in Somerset West/Cape Town to open the third Synexus Dedicated Research Site. Expansion of Stanza Research Site to include TB Research Wing.
  • Germany: Expansion at Bochum & Berlin Dedicated Research Sites.

2012

  • Poland: Synexus – Central & Eastern European HQ. Expansion in Poland at Warsaw Dedicated Research Site by acquisition of Osteomed to create the biggest Dedicated Research Site in Warsaw & expansion of new Katowice Dedicated Research Site.
  • South Africa – Expansion of Watermeyer Dedicated Research Site to add PK and PD Unit.

2010

  • Poland expansion of new Gdynia Dedicated Research Site.

2009

  • Synexus Ukraine and Germany established by acquisition of Clinpharm. Seven Dedicated Research Sites in Germany subsequently rationalised to four DRSs (Berlin, Bochum, Leipzig & Frankfurt). Ukraine set up as an administrative centre in Kiev.
  • South Africa new Dedicated Research Site at Stanza in Mamelodi. Expansion of Watermeyer Dedicated Research Site.

2008

  • Poland: Three new Dedicated Research Sites in Poland (Warsaw, Gdynia and Katowice) by acquisition of CVLCC.

2007

  • Synexus taken private by Lyceum Capital.
  • Synexus Bulgaria & South Africa established.
  • S.Africa – First Dedicated Research Site – Watermeyer in Pretoria by the acquisition of Clinical Research Centres.

2006

  • Synexus Poland established with first Dedicated Research Site in Wroclaw by the acquisition of SCM.
  • Synexus Hungary established with first Dedicated Research Site in Budapest by the acquisition of Diagnostic Units Hungary.

2005

  • Synexus- Listed on the London Stock Exchange AIM.

1998

  • Synexus formed by the merger of Edgebright Partnership and AEA Technology, plc.
  • Synexus UK established with the seven Current Dedicated Research Site established from the merger (Lancashire, Liverpool, Manchester, Midlands, Thames Valley, Scotland, Wales).

1992

  • Dr. Ian Smith opened the first dedicated clinical trial centre in Europe and the Synexus story began.